Human Umbilical Cord Blood Therapy Protects Cerebral White Matter from Systemic LPS Exposure in Preterm Fetal Sheep
Developmental Neuroscience · 2018 · 40 (3) · 258-270
DOI: 10.1159/000490943 ↗Kurz gefasst
Fachartikel in der Zeitschrift Developmental Neuroscience, online erschienen am 04.09.2018. Verfasst von Madison C B Paton und 12 weiteren Autor:innen. Beteiligte Einrichtung: The Ritchie Centre, Hudson Institute of Medical Research, Clayton, Victoria, Australia. Die Arbeit wurde bisher 49-mal zitiert (Crossref).
Abstract (Originalsprache)
Background
Infants born preterm following exposure to in utero inflammation/chorioamnionitis are at high risk of brain injury and life-long neurological deficits. In this study, we assessed the efficacy of early intervention umbilical cord blood (UCB) cell therapy in a large animal model of preterm brain inflammation and injury. We hypothesised that UCB treatment would be neuroprotective for the preterm brain following subclinical fetal inflammation.
Methods
Chronically instrumented fetal sheep at 0.65 gestation were administered lipopolysaccharide (LPS, 150 ng, 055:B5) intravenously over 3 consecutive days, followed by 100 million human UCB mononuclear cells 6 h after the final LPS dose. Controls were administered saline instead of LPS and cells. Ten days after the first LPS dose, the fetal brain and cerebrospinal fluid were collected for analysis of subcortical and periventricular white matter injury and inflammation.
Results
LPS administration increased microglial aggregate size, neutrophil recruitment, astrogliosis and cell death compared with controls. LPS also reduced total oligodendrocyte count and decreased mature myelinating oligodendrocytes. UCB cell therapy attenuated cell death and inflammation, and recovered total and mature oligodendrocytes, compared with LPS.
Conclusions
UCB cell treatment following inflammation reduces preterm white matter brain injury, likely mediated via anti-inflammatory actions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Ritchie Centre, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
- Department of Obstetrics and Gynaecology, Monash University, Clayton, Victoria, Australia.
- Department of Paediatrics, Monash Children's, Monash Health, Clayton, Victoria, Australia.
- Department of Physiology, University of Auckland, Auckland, New Zealand.
Zitieren
APA
Paton, M. C. B., Allison, B. J., Li, J., Fahey, M. C., Sutherland, A. E., Nitsos, I., Bischof, R. J., Dean, J. M., Moss, T. J. M., Polglase, G. R., Jenkin, G., McDonald, C. A., & Miller, S. L. (2018). Human Umbilical Cord Blood Therapy Protects Cerebral White Matter from Systemic LPS Exposure in Preterm Fetal Sheep. Developmental Neuroscience, 40(3), 258-270. https://doi.org/10.1159/000490943
Vancouver
Paton MCB, Allison BJ, Li J, Fahey MC, Sutherland AE, Nitsos I, et al. Human Umbilical Cord Blood Therapy Protects Cerebral White Matter from Systemic LPS Exposure in Preterm Fetal Sheep. Developmental Neuroscience. 2018;40(3):258-270. doi:10.1159/000490943
BibTeX
@article{Paton2018,
author = {Paton, Madison C B and Allison, Beth J and Li, Jingang and Fahey, Michael C and Sutherland, Amy E and Nitsos, Ilias and Bischof, Robert J and Dean, Justin M and Moss, Timothy J M and Polglase, Graeme R and Jenkin, Graham and McDonald, Courtney A and Miller, Suzanne L},
title = {Human Umbilical Cord Blood Therapy Protects Cerebral White Matter from Systemic LPS Exposure in Preterm Fetal Sheep},
journal = {Developmental Neuroscience},
year = {2018},
volume = {40},
number = {3},
pages = {258--270},
doi = {10.1159/000490943}
}
EUVIMED